Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reticulocyte Dynamic and Related Hemoglobin Variability in Hemodialysis Patients Treated With Darbepoetin Alfa and C.E.R.A.: a Randomized Controlled Trial

NCT01666301 is registered in ClinicalTrials.gov with Ospedale Regionale di Locarno as lead sponsor.

NCT NCT01666301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reticulocyte Dynamic and Related Hemoglobin Variability in Hemodialysis Patients Treated With Darbepoetin Alfa and C.E.R.A.: a Randomized Controlled Trial
Lead sponsor
Ospedale Regionale di Locarno
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2010
Completion date
April 30, 2012
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoiesis stimulating agent pharmacodynamics